Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV-free liquid rotavirus vaccine formulation comparison in healthy infants
2016-003210-27Phase 3
- Sponsor
- GSK
- Start
- Jul 2017
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Rotavirus vaccine in rotaviral diarrhea (2 arms), sponsored by GSK. Primary endpoint: Anti-diphtheria and anti-tetanus antibody concentrations.
02
Drugs
Rotavirus vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2016-003210-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003210-27.